Treatment of hemorrhagic shock with a new vasodilator.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure; D001810:Blood Volume; D004285:Dogs; D005021:Ethylamines / Q000627:therapeutic use; D000882:Haplorhini; D006339:Heart Rate; D006863:Hydrogen-Ion Concentration; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D012756:Sheep; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D005021:Ethylamines; D009946:Organothiophosphorus Compounds; D014665:Vasodilator Agents